News & Updates
Filter by Specialty:

Add-on immunotherapy improves PFS in 1L advanced or recurrent endometrial cancer
17 Apr 2023
byChristina Lau
Adding dostarlimab or pembrolizumab to standard first-line (1L) chemotherapy significantly improves progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, two phase III trials have shown.
Add-on immunotherapy improves PFS in 1L advanced or recurrent endometrial cancer
17 Apr 2023
Hysteroscopy not better than vacuum aspiration for managing incomplete miscarriage
14 Apr 2023
The use of hysteroscopy for surgical management of incomplete spontaneous abortion in individuals who intend to conceive again neither leads to more subsequent births nor shows a better safety profile compared with vacuum aspiration, according to the results of the HY-PER trial.